By Grand Rapids Anonymous
Tuesday, November 2, 2021 at 6:06:00 P.M. EDT
(ZH) A whistleblower involved in Pfizer’s pivotal phase III Covid-19 vaccine trial has leaked evidence to a notable peer-reviewed medical publication that poor practices at the contract research company she worked for raise questions about data integrity and regulatory oversight.
Brook Jackson, a now-fired regional director at Ventavia Research Group, revealed to The BMJ that vaccine trials at several sites in Texas last year had major problems – including falsified data, broke fundamental rules, and were “slow” to report adverse reactions.
When she notified superiors of the issues she found, they fired her.
A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.
GRA: What more can you add?
--GRA
Subscribe to:
Post Comments (Atom)
1 comment:
I didn't even know the vaxxx was in clinical trials. Normal clinical trials take five years? We are the clinical trial all persons that have gotten the vaxxx.
Post a Comment